The Real ROI Behind Virta's Diabetes Reversal Treatment
ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.
Virta Health Earns Validation Institute's Highest Ranking
Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.
The Western Health Advantage Team shares advice for other leaders on reversing diabetes
Meet the leaders behind the heroic effort to reverse diabetes at WHA.
Troy Remy (Canal Barge) describes why he picked Virta as part of his "people first" approach
Canal Barge's VP of HR talks about prioritizing a progressive benefits management strategy for his employee population.
Ryan Smith, DO, heard about Virta from his patients and has been tirelessly advocating for reversal ever since.
Ryan Smith, DO, shares his views on the clinical benefits of Virta’s diabetes reversal treatment and why he advocates it for his patients.
Rita King (BBVA) offers Virta because it's a game-changing benefit for her employees
BBVA VP & Employee Benefits Consultant shares the details behind their game changing transition from diabetes management to reversal.
Nathan Gregory (City of Fort Worth) partners with Virta to tackle the largest disease state in his population
The Deputy Director of HR for the City of Fort Worth talks about his partnership with Virta and the resulting paradigm shift in his benefits strategy.
Heidi Husk (Nebraska Medicine) uses Virta to change lives for the better
Nebraska Medicine's Employee Wellbeing and Safety Manager talks about caring for the caregivers and how she's used Virta to change hundreds of lives for the better.
Preliminary 5 Year Outcomes: Lasting and Transformative Health Improvements
Results show broad cardiometabolic health improvement, including blood sugar control, weight loss, and medication deprescription, with half of all diabetes drugs eliminated at 5 years.
The Rx Affordability Crisis [Webinar Replay]
For years, US policymakers from both parties have worked to improve affordability of prescription drugs with little success.
Reversing the Insulin Cost Crisis [Webinar Replay]
Each day, more health plans are looking for innovative solutions (outside of traditional diabetes management) to combat the insulin cost crisis.